Meta-Analysis of Associations Between Interleukin-10 Polymorphisms and Susceptibility to Vasculitis

References

• Ates O, Dalyan L, Hatemi G, et al. (2010). Analyses of functional IL10 and TNF-alpha genotypes in Behcet's syndrome. Mol Biol Rep, 37, 3637–41
   PubMed Web of Science ®Google Scholar
• Bartfai Z, Gaede KI, Russell KA, et al. (2003). Different gender-associated genotype risks of Wegener's granulomatosis and microscopic polyangiitis. Clin Immunol, 109, 330–7
   PubMed Web of Science ®Google Scholar
• Bloch DA, Michel BA, Hunder GG, et al. (1990). The American College of Rheumatology 1990 criteria for the classification of vasculitis – Patients and methods. Arthritis Rheumat, 33, 1068–73
   PubMed Web of Science ®Google Scholar
• Boiardi L, Casali B, Farnetti E, et al. (2006). Interleukin-10 promoter polymorphisms in giant cell arteritis. Arthritis Rheumat, 54, 4011–17
   PubMed Web of Science ®Google Scholar
• Csernok E, Trabandt A, Mueller A, et al. (1999). Cytokine profiles in Wegener's granulomatosis: predominance of type 1 (Th1) in the granulomatous inflammation. Arthritis Rheumat, 42, 742–50
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177–88
   PubMed Web of Science ®Google Scholar
• Dilek K, Ozcimen AA, Saricaoglu H, et al. (2009). Cytokine gene polymorphisms in Behcet's disease and their association with clinical and laboratory findings. Clin Exp Rheumatol, 27, S73–8
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, Minder C. (1997a). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629–34
   PubMed Web of Science ®Google Scholar
• Egger M, Smith GD, Phillips AN. (1997b). Meta-analysis: principles and procedures. BMJ, 315, 1533–7
   PubMed Web of Science ®Google Scholar
• Eskdale J, Wordsworth P, Bowman S, et al. (1997). Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus. Tissue Antigens, 49, 635–9
   PubMed Web of Science ®Google Scholar
• Guzowski D, Chandrasekaran A, Gawel C, et al. (2005). Analysis of single nucleotide polymorphisms in the promoter region of interleukin-10 by denaturing high-performance liquid chromatography. J Biomol Tech, 16, 154–66
   PubMedGoogle Scholar
• Higgins JP, Thompson SG. (2002). Quantifying heterogeneity in a meta-analysis. Stat Med, 21, 1539–58
   PubMed Web of Science ®Google Scholar
• Hsieh KS, Lai TJ, Hwang YT, et al. (2011). IL-10 promoter genetic polymorphisms and risk of Kawasaki disease in Taiwan. Dis Markers, 30, 51–9
   PubMed Web of Science ®Google Scholar
• Hsueh KC, Lin YJ, Chang JS, et al. (2009). Association of interleukin-10 A-592C polymorphism in Taiwanese children with Kawasaki disease. J Korean Med Sci, 24, 438–42
   PubMed Web of Science ®Google Scholar
• Jennette J, Falk R, Bacon P, et al. (2013). 2012 Revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Arthritis Rheumat, 65, 1–11
   PubMed Web of Science ®Google Scholar
• Lee YH, Rho YH, Choi SJ, et al. (2007). PADI4 polymorphisms and rheumatoid arthritis susceptibility: A meta-analysis. Rheumatol Int, 27, 827–33
   PubMed Web of Science ®Google Scholar
• Lee YH, Woo JH, Choi SJ, et al. (2010). Associations between osteoprotegerin polymorphisms and bone mineral density: a meta-analysis. Mol Biol Rep, 37, 227–34
   PubMed Web of Science ®Google Scholar
• Lin YJ, Lan YC, Lai CH, et al. (2014). Association of promoter genetic variants in interleukin-10 and Kawasaki disease with coronary artery aneurysms. J Clin Lab Anal, 28, 461–4
   PubMed Web of Science ®Google Scholar
• Lopez P, Gutierrez C, Suarez A. (2010). IL-10 and TNFalpha genotypes in SLE. J Biomed Biotechnol, 2010, 838390
   Google Scholar
• Menegatti E, Davit A, Francica S, et al. (2009). Genetic factors associated with rheumatoid arthritis and systemic vasculitis: Evaluation of a panel of polymorphisms. Dis Markers, 27, 217–23
   PubMed Web of Science ®Google Scholar
• Mizuki N, Meguro A, Ota M, et al. (2010). Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci. Nat Genetics, 42, 703–6
   PubMed Web of Science ®Google Scholar
• Monach PA, Merkel PA. (2010). Genetics of vasculitis. Curr Opin Rheumatol, 22, 157–63
   PubMed Web of Science ®Google Scholar
• Montes-Cano MA, Conde-Jaldon M, Garcia-Lozano JR, et al. (2013). HLA and non-HLA genes in Behcet's disease: A multicentric study in the Spanish population. Arthritis Res Therapy, 15, R145
   PubMed Web of Science ®Google Scholar
• Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. (2001). Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol, 19, 683–765
   PubMed Web of Science ®Google Scholar
• Murakozy G, Gaede KI, Ruprecht B, et al. (2001). Gene polymorphisms of immunoregulatory cytokines and angiotensin-converting enzyme in Wegener's granulomatosis. J Mol Med, 79, 665–70
   PubMed Web of Science ®Google Scholar
• Nath SK, Harley JB, Lee YH. (2005). Polymorphisms of complement receptor 1 and interleukin-10 genes and systemic lupus erythematosus: A meta-analysis. Hum Genet, 118, 225–34
   PubMed Web of Science ®Google Scholar
• Rueda B, Roibas B, Martin J, Gonzalez-Gay MA. (2007). Influence of interleukin 10 promoter polymorphisms in susceptibility to giant cell arteritis in Northwestern Spain. J Rheumatol, 34, 1535–9
   PubMed Web of Science ®Google Scholar
• Sakane T, Takeno M, Suzuki N, Inaba G. (1999). Behcet's disease. N Engl J Med, 341, 1284–91
   PubMed Web of Science ®Google Scholar
• Shahram F, Nikoopour E, Rezaei N, et al. (2011). Association of interleukin-2, interleukin-4 and transforming growth factor-beta gene polymorphisms with Behcet's disease. Clin Exp Rheumatol, 29, S28–31
   PubMed Web of Science ®Google Scholar
• Song GG, Lee YH. (2014). A Meta-analysis of the relation between chemokine receptor 5 delta32 polymorphism and multiple sclerosis susceptibility. Immunol Investig, 43, 299–311
   PubMed Web of Science ®Google Scholar
• Spriewald BM, Witzke O, Wassmuth R, et al. (2005). Distinct tumour necrosis factor alpha, interferon gamma, interleukin 10, and cytotoxic T cell antigen 4 gene polymorphisms in disease occurrence and end stage renal disease in Wegener's granulomatosis. Ann Rheumat Dis, 64, 457–61
   PubMed Web of Science ®Google Scholar
• Stroup DF, Berlin JA, Morton SC, et al. (2000). Meta-analysis of observational studies in epidemiology: A proposal for reporting. JAMA, 283, 2008–12
   PubMed Web of Science ®Google Scholar
• Taga K, Tosato G. (1992). IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol, 148, 1143–8
   PubMed Web of Science ®Google Scholar
• Turner DM, Williams DM, Sankaran D, et al. (1997). An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet, 24, 1–8
   PubMedGoogle Scholar
• Wallace GR, Kondeatis E, Vaughan RW, et al. (2007). IL-10 genotype analysis in patients with Behcet's disease. Hum Immunol, 68, 122–7
   PubMed Web of Science ®Google Scholar
• Wu Z, Zheng W, Xu J, et al. (2014). IL10 polymorphisms associated with Behcet's disease in Chinese Han. Hum Immunol, 75, 271–6
   PubMed Web of Science ®Google Scholar
• Yang J, Li CR, Li YB, et al. (2003). [The correlation between Kawasaki disease and polymorphisms of Tumor necrosis factor alpha and interleukin-10 gene promoter]. Chin J Pediatr, 41, 598–602
   Google Scholar